medplus share longNSE:MEDPLUS
medplus share long
note:
don't buy / sell this stock, please trade with your own research and responsibility.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.35 INR
654.73 M INR
56.25 B INR
48.61 M
About MEDPLUS HEALTH SERV LTD
Sector
Industry
CEO
Madhukar Reddy Gangadi
Website
Headquarters
Hyderabad
Founded
2006
ISIN
INE804L01022
FIGI
BBG013YXGVH8
MedPlus Health Services Ltd. engages in the provision of operation of pharmacies. It operates through the following segments: Retail, Diagnostics, and Others. The Retail segment focuses on the sale of pharmaceuticals and general items. The Diagnostics segment involves the pathology and radiology services. The Others segment includes insurance broking business. Its pharmacies carry medicines, vitamins, medical devices, test kits, and fast-moving consumer goods. It also conducts pathological services and distributes medical and surgical supplies through RiteCure and its online pharmacy Medplus Mart. The company was founded by Madhukar Gangadi in 2006 and is headquartered in Hyderabad, India.
Did you Ride the Medplus Momentum?September 4, 2024
On Sep 2, 2024, we had posted our analysis of a short-term uptrend in Medplus. Here is the chart we initially published
As anticipated by us, Medplus breached the 50%, 61.8% and 78.6% Fib levels in just 2 trading days.
From Rs. 685, the stock zoomed to Rs. 729, giving around
Ride the Medplus Momentum: Short-Term Trade AlertSeptember 2, 2024
Medplus seems to have completed a triple correction and is on the rise.
It created a demand zone between Rs 595 and Rs 605 level.
The stock retested the demand zone for the second time in the last week of August, and as expected, buyers came and moved the stock up toward the
Take Medplus Health for almost double targetTake entry at cmp 669
Target 1227
Term 1.5 year to 2 year
Next average price at 572Rs...at this level invest same amount and make weekly closing basis stop loss of 547Rs......
Downside will be limited and upper side will be open sky so this will be good deal for investors...
we can see W pattern
Medplus - Good volumes. Best above 679Medplus - Low risk setup. Volumes increased. FII/DII already invested.
One can enter above 679 and average up as it moves, with strict stop loss of 632.
Please note this stock may frustrate you and highly suggest to keep accumulating this stock upwards
Disclaimer : Educational Post. Please do you
MedPlus- bottoming outGreat management
Pan India growth
Expansion and franchise model doing well
Make their own medicines at lowest cost
Only issue is margins at this rate
They dont have pricing power
MEDPLUS - Weekly AnalysisIn the Weekly Chart of MEDPLUS ,
we can see that, it is at decision making point.
Enter on breaking Candle's High with low as SL and Go long.
Expected momentums are shown in chart.
MEDPLUS reversingMEDPLUS is reversing after great downfall.,
good greencandle with good volume
good for swing trade
Medplus : Bounce from Support regionMed plus :
Strong Bounce from Solid support region,
expecting up-move from here
support at 580
Risky though!
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MEDPLUS is 679.15 INR — it has decreased by −0.18% in the past 24 hours. Watch MEDPLUS HEALTH SERVICES LIMITE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange MEDPLUS HEALTH SERVICES LIMITE stocks are traded under the ticker MEDPLUS.
MEDPLUS stock has risen by 1.65% compared to the previous week, the month change is a 3.53% rise, over the last year MEDPLUS HEALTH SERVICES LIMITE has showed a −17.28% decrease.
We've gathered analysts' opinions on MEDPLUS HEALTH SERVICES LIMITE future price: according to them, MEDPLUS price has a max estimate of 1,000.00 INR and a min estimate of 805.00 INR. Watch MEDPLUS chart and read a more detailed MEDPLUS HEALTH SERVICES LIMITE stock forecast: see what analysts think of MEDPLUS HEALTH SERVICES LIMITE and suggest that you do with its stocks.
MEDPLUS reached its all-time high on Jan 20, 2022 with the price of 1,343.00 INR, and its all-time low was 570.00 INR and was reached on Nov 10, 2022. View more price dynamics on MEDPLUS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEDPLUS stock is 1.81% volatile and has beta coefficient of −0.16. Track MEDPLUS HEALTH SERVICES LIMITE stock price on the chart and check out the list of the most volatile stocks — is MEDPLUS HEALTH SERVICES LIMITE there?
Today MEDPLUS HEALTH SERVICES LIMITE has the market capitalization of 81.19 B, it has decreased by −5.11% over the last week.
Yes, you can track MEDPLUS HEALTH SERVICES LIMITE financials in yearly and quarterly reports right on TradingView.
MEDPLUS HEALTH SERVICES LIMITE is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
MEDPLUS earnings for the last quarter are 1.20 INR per share, whereas the estimation was 0.75 INR resulting in a 60.00% surprise. The estimated earnings for the next quarter are 1.95 INR per share. See more details about MEDPLUS HEALTH SERVICES LIMITE earnings.
MEDPLUS HEALTH SERVICES LIMITE revenue for the last quarter amounts to 14.89 B INR, despite the estimated figure of 14.95 B INR. In the next quarter, revenue is expected to reach 15.86 B INR.
MEDPLUS net income for the last quarter is 143.63 M INR, while the quarter before that showed 333.96 M INR of net income which accounts for −56.99% change. Track more MEDPLUS HEALTH SERVICES LIMITE financial stats to get the full picture.
No, MEDPLUS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 21.72 K employees. See our rating of the largest employees — is MEDPLUS HEALTH SERVICES LIMITE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDPLUS HEALTH SERVICES LIMITE EBITDA is 3.77 B INR, and current EBITDA margin is 6.33%. See more stats in MEDPLUS HEALTH SERVICES LIMITE financial statements.
Like other stocks, MEDPLUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDPLUS HEALTH SERVICES LIMITE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDPLUS HEALTH SERVICES LIMITE technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDPLUS HEALTH SERVICES LIMITE stock shows the sell signal. See more of MEDPLUS HEALTH SERVICES LIMITE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.